Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$46.41M$46.41Mderived−6.9% vs Q4 2024 Net Income$1.95M$1.95Mderived−47.2% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$6,829,000+146.8% Operating Cash Flowderived$7,569,000−38.8% Free Cash Flowderived$6,492,000−39.3% Margins · derivedOperating margin14.7%+9.2 pt vs Q4 2024
Net margin4.2%−3.2 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 13, 2026 · 72 d after period end